Cargando…
The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice
BACKGROUND: Breast cancer (BC) and differentiated thyroid cancer (TC) are two common cancer types with the highest incidence in women. BC and TC can develop synchronous or metachronous and the occurrence of both is higher than expected by chance. This study aimed to examine the association between B...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511724/ https://www.ncbi.nlm.nih.gov/pubmed/36163009 http://dx.doi.org/10.1186/s12885-022-10069-6 |
_version_ | 1784797701104205824 |
---|---|
author | Piek, Marceline W. de Boer, Jan Paul van Duijnhoven, Frederieke van der Wal, Jacqueline E. Vriens, Menno van Leeuwaarde, Rachel S. van der Ploeg, Iris M. C. |
author_facet | Piek, Marceline W. de Boer, Jan Paul van Duijnhoven, Frederieke van der Wal, Jacqueline E. Vriens, Menno van Leeuwaarde, Rachel S. van der Ploeg, Iris M. C. |
author_sort | Piek, Marceline W. |
collection | PubMed |
description | BACKGROUND: Breast cancer (BC) and differentiated thyroid cancer (TC) are two common cancer types with the highest incidence in women. BC and TC can develop synchronous or metachronous and the occurrence of both is higher than expected by chance. This study aimed to examine the association between BC and TC in the Netherlands. METHODS: This is a retrospective cohort study during the period of 1989–2020 retrieved from the Netherlands Cancer Registry (NCR). Patients diagnosed with BC-TC and BC alone as control group and TC-BC and TC alone as control group were included. The primary outcome was the standardized incidence ratio (SIR) of BC-TC and TC-BC. Secondary outcomes included data on the demographics, type of malignancy, treatment and overall survival (OS). RESULTS: The incidence of TC among 318.002 women with BC (BC-TC) was 0.1% (423 patients) (SIR = 1.86 (95% CI: 1.40–2.32)) and the incidence of BC among 12,370 patients with TC (TC-BC) was 2.9% (355 patients) (SIR = 1.46 (95% CI: 1.09–1.83)). BC-TC patients were younger compared to the BC alone group at BC diagnosis (55 vs 60 years, p < 0.001). The age-adjusted odds ratio to develop TC was not significantly increased for patients who received chemotherapy and radiotherapy. Most TC cases were synchronous tumors after BC diagnosis (19%) with a TNM stage 1. Only 6% of the BC tumors after TC occurred synchronous with a TNM stage 1 in most cases. The OS of all groups was the most favorable in patients with both BC and TC compared to BC- and TC alone. CONCLUSION AND RELEVANCE: The SIR of TC after BC diagnosis and BC after TC diagnosis was higher than predicted based on the rates of the general population. TC and BC as second primary tumors were diagnosed in an early stage and did not affect overall survival. Therefore, Dutch women who have been treated for BC or TC require no special surveillance for their thyroid- and breast gland. |
format | Online Article Text |
id | pubmed-9511724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95117242022-09-27 The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice Piek, Marceline W. de Boer, Jan Paul van Duijnhoven, Frederieke van der Wal, Jacqueline E. Vriens, Menno van Leeuwaarde, Rachel S. van der Ploeg, Iris M. C. BMC Cancer Research BACKGROUND: Breast cancer (BC) and differentiated thyroid cancer (TC) are two common cancer types with the highest incidence in women. BC and TC can develop synchronous or metachronous and the occurrence of both is higher than expected by chance. This study aimed to examine the association between BC and TC in the Netherlands. METHODS: This is a retrospective cohort study during the period of 1989–2020 retrieved from the Netherlands Cancer Registry (NCR). Patients diagnosed with BC-TC and BC alone as control group and TC-BC and TC alone as control group were included. The primary outcome was the standardized incidence ratio (SIR) of BC-TC and TC-BC. Secondary outcomes included data on the demographics, type of malignancy, treatment and overall survival (OS). RESULTS: The incidence of TC among 318.002 women with BC (BC-TC) was 0.1% (423 patients) (SIR = 1.86 (95% CI: 1.40–2.32)) and the incidence of BC among 12,370 patients with TC (TC-BC) was 2.9% (355 patients) (SIR = 1.46 (95% CI: 1.09–1.83)). BC-TC patients were younger compared to the BC alone group at BC diagnosis (55 vs 60 years, p < 0.001). The age-adjusted odds ratio to develop TC was not significantly increased for patients who received chemotherapy and radiotherapy. Most TC cases were synchronous tumors after BC diagnosis (19%) with a TNM stage 1. Only 6% of the BC tumors after TC occurred synchronous with a TNM stage 1 in most cases. The OS of all groups was the most favorable in patients with both BC and TC compared to BC- and TC alone. CONCLUSION AND RELEVANCE: The SIR of TC after BC diagnosis and BC after TC diagnosis was higher than predicted based on the rates of the general population. TC and BC as second primary tumors were diagnosed in an early stage and did not affect overall survival. Therefore, Dutch women who have been treated for BC or TC require no special surveillance for their thyroid- and breast gland. BioMed Central 2022-09-26 /pmc/articles/PMC9511724/ /pubmed/36163009 http://dx.doi.org/10.1186/s12885-022-10069-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Piek, Marceline W. de Boer, Jan Paul van Duijnhoven, Frederieke van der Wal, Jacqueline E. Vriens, Menno van Leeuwaarde, Rachel S. van der Ploeg, Iris M. C. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice |
title | The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice |
title_full | The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice |
title_fullStr | The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice |
title_full_unstemmed | The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice |
title_short | The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice |
title_sort | co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511724/ https://www.ncbi.nlm.nih.gov/pubmed/36163009 http://dx.doi.org/10.1186/s12885-022-10069-6 |
work_keys_str_mv | AT piekmarcelinew thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT deboerjanpaul thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT vanduijnhovenfrederieke thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT vanderwaljacquelinee thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT vriensmenno thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT vanleeuwaarderachels thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT vanderploegirismc thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT piekmarcelinew cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT deboerjanpaul cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT vanduijnhovenfrederieke cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT vanderwaljacquelinee cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT vriensmenno cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT vanleeuwaarderachels cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice AT vanderploegirismc cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice |